A pilot trial of itraconazole pharmacokinetics in patients with metastatic breast cancer
K
Kathy Miller, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to look at how the body processes and breaks down itraconazole.
Description
The purpose of this study is to look at how the body processes and breaks down itraconazole.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Breast Cancer
-
Age: Between 18 Years - 100 Years
-
Gender: Female
Updated on
18 Apr 2024.
Study ID: 1011003560 (0809-10)
